DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
- 1Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, China
- 2State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China
A Corrigendum on
DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
by Wang Z, Wang Y, Zhu S, Liu Y, Peng X, Zhang S, Zhang Z, Qiu Y, Jin M, Wang R, Zhong Y and Kong D (2018). Front. Pharmacol. 9:1450. doi: 10.3389/fphar.2018.01450
In the original article, there was a mistake in Figure 2 as published. The images that represent a minor part of the whole pictures were used in the original published paper. The corrected Figure 2 appears below, with the new images covering over 90% of the whole pictures.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Figure 2 Effect of DT-13 on colony formation capability of prostate cancer cells. (A) Clonogenic assay was carried out to assess the effect of DT-13 on the colony formation capability of PC3 and DU145 cells. After treatment with 0, 2.5, 5, and 10 μM of DT-13 for 48 h, cells were incubated in agarose plates for 14 days and then stained with crystal violet. (B) The histograms represent the number of colonies of PC3 and DU145 cells following treatment with DT-13, compared to those of control cells. Data are mean ± SD (n = 3), representative of three independent experiments. *P< 0.05, **P< 0.01, ***P< 0.001, compared with control.
Keywords: DT-13, prostate cancer, anti-proliferation, anti-metastasis, apoptosis, PI3K/Akt pathway
Citation: Wang Z, Wang Y, Zhu S, Liu Y, Peng X, Zhang S, Zhang Z, Qiu Y, Jin M, Wang R, Zhong Y and Kong D (2020) Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway. Front. Pharmacol. 11:462. doi: 10.3389/fphar.2020.00462
Received: 15 February 2020; Accepted: 24 March 2020;
Published: 08 April 2020.
Edited and reviewed by: Zhi Shi, Jinan University, China
Copyright © 2020 Wang, Wang, Zhu, Liu, Peng, Zhang, Zhang, Qiu, Jin, Wang, Zhong and Kong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ran Wang, d2FuZ3JhbkB0bXUuZWR1LmNu; Yuxu Zhong, eXV4dXpob25nMjAwOEBhbGl5dW4uY29t; Dexin Kong, a29uZ2RleGluQHRtdS5lZHUuY24=